Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page
provident_logo_blue Created with Sketch. Provident Healthcare Partners

Q3-2021 Laboratory & Diagnostic Services Update

Provident Healthcare Partners
Skip to the end of the Expertise Menu

Q3-2021 Laboratory & Diagnostic Services Update

The laboratory services and diagnostics sectors have seen  aggressive M&A activity in the past year. Both major and mid-sized market players have continued to consolidate at a high level. Following a strong first half of the year Q3 saw 32 Diagnostic and Laboratory Services deals including Ignenomix’s $1.4 billion acquisition of Vitrolife.

With COVID-19 revolutionizing the diagnostics industry, point of care solutions have become a leading trend in the space. The ability to rapidly test for infection diseases at an individual’s home and store results in a secure digitalized environment for convenient access improves both efficiency and efficacy. Recent deals in this space support this trend as CA Healthcare Acquisition Corp, a healthcare  focused SPAC, engaged in a reverse merger with Lumira Dx which provides point of care diagnostic services. Thus, Provident anticipates consolidation in the industry will center around simplifying the diagnostics process through various leading-edge technologies. Additionally, with healthcare SPACs raising over $15 billion in 2021, the firm anticipates a frenzy of SPAC acquisitions over the course of the next two years in the diagnostics services space.

To print and download the full Laboratory & Diagnostic Services Update report, please click below…

[holo_button icon=”/wp-content/uploads/2021/10/Q3-2021-Lab-Dx-Services-Newsletter.pdf” link=”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]

 

Sources: SEC Filings; Company Press Releases, and Reports; IBISWorld; Capital IQ; PHP Estimates and Research. This document has been compiled with publicly available information. Provident Healthcare Partners, LLC makes no guarantee of its accuracy or completeness. No data or statement should be construed to be a recommendation for the purchase, sale, or retention of any security.